| 2024-04-01 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Financial Officer | 4,000 0.0033% | $58.66 | $234,640 | -28.4% | |
| 2024-03-01 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Financial Officer | 6,000 0.0049% | $63.22 | $379,340 | -25.65% | |
| 2024-02-12 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Financial Officer | 1,431 0.0012% | $67.77 | $96,974 | -27.14% | |
| 2024-01-29 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Financial Officer | 906 0.0008% | $64.14 | $58,109 | -19.54% | |
| 2024-01-22 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Financial Officer | 3,551 0.003% | $65.00 | $230,801 | -15.29% | |
| 2024-01-16 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Financial Officer | 2,235 0.0019% | $66.81 | $149,317 | -16.92% | |
| 2023-11-30 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Financial Officer | 14,158 0.0122% | $54.73 | $774,884 | +6.21% | |
| 2023-07-03 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Financial Officer | 6,779 0.006% | $89.97 | $609,928 | -46% | |
| 2023-06-05 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Financial Officer | 37,570 0.0329% | $89.55 | $3.36M | -44.47% | |
| 2023-06-05 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Financial Officer | 69,779 0.0606% | $88.80 | $6.2M | -44.47% | |
| 2019-08-29 | Apellis Pharmaceuticals, Inc. APLS | Chief Financial Officer | 23,398 0.0367% | $29.71 | $695,260 | +1.94% |